Skip to Main Content

Author Details

Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
2006
116
23
PMIDPaper TitleJournal TitlePublished Year
38049220Withdraw or Deposit?Int J Radiat Oncol Biol Phys2024
37914593Five Fraction Accelerated Partial Breast Irradiation Versus Intraoperative Radiation Therapy for Early-Stage Breast Cancer.Clin Breast Cancer2024
37857985Intraoperative Radiation Therapy for Early-Stage Breast Cancer: Updated Outcomes from a Single-Institution Experience.Ann Surg Oncol2024
36300837Contour similarity and its implication on inverse prostate SBRT treatment planning.J Appl Clin Med Phys2023
37966114Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer.J Clin Invest2023
38047224Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy.Adv Radiat Oncol2023
37144947Transperineal ultrasound is a good alternative for intra-fraction motion monitoring for prostate stereotactic body radiotherapy.J Appl Clin Med Phys2023
37031006Disparities in Prostate Cancer Diagnoses Among Persons Experiencing Homelessness.Eur Urol2023
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
34016556Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy.Eur Urol Oncol2022
35662504Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate.Eur Urol Focus2022
35713598A multi-institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1-2N1 breast cancer.Cancer2022
36070558Cost effectiveness of treatment strategies for high risk prostate cancer.Cancer2022
36206501Prostate Cancer Screening Disparities in Persons Experiencing Homelessness.JCO Oncol Pract2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
34656435<sup>125</sup>I Interstitial brachytherapy with or without androgen deprivation therapy among unfavorable-intermediate and high-risk prostate cancer.Brachytherapy2022
34416341Logistic Regression in Clinical Studies.Int J Radiat Oncol Biol Phys2022
32768561Use of a Radiation Tumor Bed Boost After Breast-Conserving Surgery and Whole-Breast Irradiation: Time Trends and Correlates.Int J Radiat Oncol Biol Phys2021
33716120No Longer a Match: Trends in Radiation Oncology National Resident Matching Program (NRMP) Data from 2010-2020 and Comparison Across Specialties.Int J Radiat Oncol Biol Phys2021
33539968A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients.Int J Radiat Oncol Biol Phys2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
33941352In Regard to Zietman.Pract Radiat Oncol2021
33985797Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.Eur Urol2021
34196715Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.JAMA Netw Open2021
33433786TARGIT-R (Retrospective): 5-Year Follow-Up Evaluation of Intraoperative Radiation Therapy (IORT) for Breast Cancer Performed in North America.Ann Surg Oncol2021
33393051Outcomes with Partial Breast Irradiation vs. Whole Breast Irradiation: a Meta-Analysis.Ann Surg Oncol2021
32891796Radiation Oncology Resident Quality by National Resident Matching Program Metrics From 2007 to 2018.Int J Radiat Oncol Biol Phys2021
31562688Outcomes with intraoperative radiation therapy for early-stage breast cancer.Breast J2020
31813740Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapy.Brachytherapy2020
31928640Cleaning without SOAP: How Program Directors Should Respond to Going Unmatched in 2020.Int J Radiat Oncol Biol Phys2020
31928637Yes, Nodal Recurrence of Prostate Cancer is Potentially Curable.Int J Radiat Oncol Biol Phys2020
31790825Educators' Perspectives on the Association of Residents in Radiation Oncology Survey of Residents' Concerns.Pract Radiat Oncol2020
33216272Treatment Options in Oligometastatic Disease in Prostate Cancer: Thinking Outside the Box.Curr Treat Options Oncol2020
33134438Management of Oligometastatic Prostate Cancer.Appl Radiat Oncol2020
32976795In Reply to Pohar.Int J Radiat Oncol Biol Phys2020
32918340Treatment of diffuse cutaneous metastases from breast cancer.Breast J2020
32698971Taking a Step in the Right Direction for Radiation Oncology.Int J Radiat Oncol Biol Phys2020
32311445Commentary RE: Androgen Deprivation with Radiation Therapy Compared with Radiation Therapy Alone for Locally Advanced Prostatic Carcinoma: A Randomized Comparative Trial of the Radiation Therapy Oncology Group.Urology2020
32349020Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Pilot Study.Am J Clin Oncol2020
31502371Initial outcomes with image-guided partial breast irradiation delivered with intensity-modulated radiation therapy.Breast J2020
31549437Revisiting TARGIT-A and intraoperative radiation therapy for breast cancer.Breast J2020
30446400Outcomes in Organ Transplant Recipients With Prostate Cancer Treated With Radiotherapy.Clin Genitourin Cancer2019
30253236Cost and Cost-Effectiveness of Image Guided Partial Breast Irradiation in Comparison to Hypofractionated Whole Breast Irradiation.Int J Radiat Oncol Biol Phys2019
31264293Long-term complications and reconstruction failures in previously radiated breast cancer patients receiving salvage mastectomy with autologous reconstruction or tissue expander/implant-based reconstruction.Breast J2019
31238166Long-Term Outcomes After Autologous or Tissue Expander/Implant-Based Breast Reconstruction and Postmastectomy Radiation for Breast Cancer.Pract Radiat Oncol2019
31059665Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy.J Urol2019
30721720Ten-Year Outcomes of Moderately Hypofractionated (70 Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate Cancer.Int J Radiat Oncol Biol Phys2019
30496876Trends in Radiation Oncology Residency Applicant Interview Experiences and Post-Interview Communication.Int J Radiat Oncol Biol Phys2019
30366007Contemporary Guidelines in Whole-Breast Irradiation: An Alternative Perspective.Int J Radiat Oncol Biol Phys2019
27635622Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis.Am J Clin Oncol2018
  • 1 - 50 of 116

Recommended Authors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2017
Number of shared co-authors 16
Stanford University
Career Start Year 2014
Number of shared co-authors 25
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 25
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 17
University of Michigan ann arbor
Career Start Year 2013
Number of shared co-authors 42
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 5
Stanford University
Career Start Year 2012
Number of shared co-authors 6
Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 36
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 25
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 5
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 16
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 7
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 4
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 15
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 2
Cedars Sinai Medical Center
Career Start Year 2005
Number of shared co-authors 16
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 14
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 23
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 32
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 5
Stanford University
Career Start Year 1999
Number of shared co-authors 30
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 6
University of Chicago
Career Start Year 1997
Number of shared co-authors 25
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 20
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 21
University of California los angeles
Career Start Year 1988
Number of shared co-authors 44
Sutter Cancer Centers Radiation Oncology Services
Career Start Year 1987
Number of shared co-authors 43
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 50
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 52

Collaborators

Cleveland Clinic
Co-authored papers 34
Cleveland Clinic
Co-authored papers 22
Cleveland Clinic
Co-authored papers 18
Mayo Clinic
Co-authored papers 11
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 8
university of california los angeles Medical Center
Co-authored papers 8
University Hospital and University of Zurich
Co-authored papers 7
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 7
Mayo Clinic
Co-authored papers 7
Mayo Clinic
Co-authored papers 7
Fox Chase Cancer Center
Co-authored papers 6
University of Maryland School of Medicine
Co-authored papers 6
University of California los angeles
Co-authored papers 6
Princess Margaret Cancer Centre, University of Toronto
Co-authored papers 5
Huntsman Cancer Institute, University of Utah
Co-authored papers 5
Universitatsklinikum Hamburg-Eppendorf
Co-authored papers 5
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 5
Oslo University Hospital
Co-authored papers 5
Mayo Clinic
Co-authored papers 5
Ascension Providence Hospital
Co-authored papers 5
University of Michigan ann arbor
Co-authored papers 5
University of California los angeles
Co-authored papers 5
Johns Hopkins University
Co-authored papers 5
Washington University School of Medicine
Co-authored papers 5
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
University of California los angeles
Co-authored papers 5
David Geffen School of Medicine, University of California los angeles
Co-authored papers 5
Oslo University Hospital
Co-authored papers 5
Duke University School of Medicine
Co-authored papers 5
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5